$72.89
arrow_drop_down0.74%Key Stats | |
---|---|
Open | $73.44 |
Prev. Close | $73.44 |
EPS | -15.35 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 71.65 | 73.60 |
52 Week Range | 62.55 | 170.47 |
Ratios | |
---|---|
EPS | -15.35 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Is It Time to Buy August's Worst-Performing Nasdaq Stocks?
Moderna's Investigational Mpox Vaccine More Effective Than Current Approved Shot, Animal Study Shows
Could This Be the Catalyst Novavax Needs to Get Its Stock Rallying Again?
Moderna, Inc. Shareholders - Robbins LLP Reminds MRNA Stockholders of the Class Action Lawsuit Against the Company – Seek Counsel Today
MRNA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Moderna, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
MODERNA, INC. (NASDAQ: MRNA) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Moderna, Inc. Investors of Upcoming Deadline